NioCorp Developments Ltd. press release

Market Regulation Services - Trading Halt - Axcan Pharma Inc. - AXP

2006-09-29

NASDAQ - Nasdaq Stock Market · Niobium · Scandium · Titanium · Rare Earth Elements · United States

TORONTO, Sept. 29 /CNW/ - The following issues have been halted by Market Regulation Services (RS):

Issuer Name: Axcan Pharma Inc. TSX Ticker Symbol: AXP Time of Halt: 12:44 EDT Reason for Halt: Pending News

Earlier from NioCorp Developments Ltd.

Conclusion of an agreement in principle with respect to a qualifying transaction between DCB Capital Inc. and Opsens Inc. 2006-07-12
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer 2006-05-10
Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006 2006-05-04